For a link to the pdf of this release please click here
AUSTIN, Texas — January 28 — Aspira Women’s Health Inc. (Nasdaq: AWH), a bioanalytical-based women’s health company, today announced that it expanded access and has become a participating laboratory network provider, for all Pennsylvania and West Virginia commercial health insurance products of Highmark. Aspira provides the OVA1® and OVERA® tests which detect the risk of ovarian malignancy in women with adnexal masses.
Highmark, Inc., an independent licensee of the BlueCross BlueShield (BCBSA) Association, operates health insurance plans in Pennsylvania, Delaware, and West Virginia that serve more than 4.4 million members. “In spite of a Covid impacted year, we increased our total in-network access by bringing those with in-network benefits for our life-saving testing to over 154M individuals.” stated Valerie Palmieri, President and CEO of ASPiRA Women's Health Inc. “Having participating provider contracts is imperative to ensure more women have access to the best care.”